Results 71 to 80 of about 5,556 (168)
ABSTRACT Background Pulmonary vein isolation (PVI) using pulsed field ablation (PFA) for atrial fibrillation (AF) is becoming increasingly widespread. However, characteristics of atrial tachycardia (AT) recurrence after PFA remain unclear. We aimed to investigate characteristics of AT recurrence in comparison with AF recurrence after PFA‐based PVI ...
Kohei Ukita +6 more
wiley +1 more source
Predictors of atrial fibrillation recurrence after cryoballoon ablation
Tolga Aksu,1 Erkan Baysal,2 Tümer Erdem Guler,1 Sukriye Ebru Golcuk,3 İsmail Erden,1 Kazim Serhan Ozcan11Department of Cardiology, Derince Education and Research Hospital, Kocaeli, 2Department of Cardiology, Diyarbakir Education and Research ...
Golcuk SE +5 more
core
Shorter cryoballoon applications times do effect efficacy but result in less phrenic nerve injury:Results of the randomized 123 study [PDF]
Background The second-generation cryoballoon significantly improves outcome of pulmonary vein isolation (PVI) but may cause more complications than the first generation. Currently, no consensus regarding optimal cryoballoon application time exists.
Marcoen F. Scholten +26 more
core +2 more sources
Two competing cryoballoon technologies for single shot pulmonary vein isolation
Following its introduction into clinical practice, the cryoballoon (CB) has proved to be an alternative for pulmonary vein isolation (PVI) in patients with paroxysmal and persistent atrial fibrillation (AF). In comparison with the standard radiofrequency
El Hamriti, Mustapha (Dr. med.) +10 more
core +1 more source
PolarX Cryoballoon metrics predicting successful pulmonary vein isolation: targets for ablation of atrial fibrillation [PDF]
AIM: Evaluate the novel PolarX Cryoballoon in atrial fibrillation (AF) catheter ablation through a propensity-matched comparison with the Arctic Front Advance (AFA).
Waddingham, Peter H +18 more
core +1 more source
Central Illustration: In a study investigating AF recurrence after PVI with RFA, CBA, and PFA, elevated NT‐proBNP emerged as a strong predictor of recurrence within the first year, outperforming other clinical measures. Color‐coded recurrence‐free survival probability charts derived from these data are proposed to support individualized clinical ...
Johannes Bruss +11 more
wiley +1 more source
Cryoballoon in atrial fibrillation ablation.
Encouraging results of ablation therapy in patients with paroxysmal atrial fibrillation (AF) have prompted changes in professional practice guidelines.
Schmidt, M;Dorwarth, U;Straube, F;Wankerl, M;Krieg, J;Leber, AW;Huber, A;Hoffmann, E
core
Documented OSAS identified a higher‐risk cardiometabolic phenotype in patients undergoing AF ablation, including greater obesity, hypertension, diabetes, persistent AF, and adverse lipid markers. However, it did not independently predict post‐ablation rhythm‐related outcomes in either the registry cohort or the actively followed cohort.
Yazan Mohsen +9 more
wiley +1 more source
Background Diaphragmatic compound motor action potential (CMAP) monitoring helps prevent phrenic nerve palsy during cryoballoon ablation (CBA) for atrial fibrillation.
Keigo Yamamoto +2 more
doaj +1 more source
Cryoballoon ablation of atrial fibrillation in patients with atypical right pulmonary vein anatomy
International audienceBackground - Cryoballoon ablation is widely used for pulmonary vein isolation in patients with atrial fibrillation. There are no data regarding the clinical efficacy of cryoballoon ablation in patients with atypical right pulmonary ...
Coquard, C +11 more
core +1 more source

